GCL
COEPW

Glazer Capital LLC’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Glazer Capital LLC’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-803,312
Closed -$208K – 816
2021
Q3 		$208K Sell
803,312
-88,205
-10% -$33.5K ﹤0.01% 675
2021
Q2 		$481K Buy
+891,517
New +$454K 0.01% 622

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Glazer Capital LLC's COEPW Position: Q4 2021 in Review

Glazer Capital LLC sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2021, closing a stake of 803,312 shares — an estimated $208K sold.

Glazer Capital LLC first reported a position in COEPW in Q2 2021 and held it in 2 quarters. The position peaked at $481K in Q2 2021. 21 funds tracked by Wall St. Rank hold COEPW as of Q4 2021.

  • Glazer Capital LLC reported no remaining Coeptis Therapeutics Warrants position as of Q4 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 803,312 Coeptis Therapeutics Warrants shares in Q4 2021, an estimated $208K.
  • Glazer Capital LLC first reported a position in Coeptis Therapeutics Warrants in Q2 2021 and held it in 2 quarters.
  • Glazer Capital LLC's Coeptis Therapeutics Warrants position peaked at $481K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2021.

Based on Glazer Capital LLC's 13F filing for Q4 2021, filed 14 Feb 2022.